Nov 04, 2019
Dracen Pharmaceuticals announces DRP-104 presentations at the 2019 Society of Immunotherapy of Cancer (SITC) Meeting
Sep 30, 2019
BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria
Sep 25, 2019
Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
Aug 27, 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Aug 22, 2019
Torque Expands Leadership Team with Appointment of Sok Cheng Soh as CFO and Ana Radeljevic as VP, Head of Business Operations
Jul 16, 2019
Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells
Jul 04, 2019
Kanazawa University Research: Cancer Genes and the Tumor Milieu
Jun 18, 2019
FDA Grants Fast Track Designation for Torque's First Deep-Primed T Cell Cancer Immunotherapy Program, TRQ-1501
Apr 02, 2019
Actym Therapeutics Will Present Data at the 2019 American Association for Cancer Research Annual Meeting
Apr 01, 2019
IO Biotech Presents Data on an Immunomodulatory CCL22-based Vaccine at the American Association for Cancer Research Annual Meeting 2019
Mar 21, 2019
BioInvent Unveils Broad Anti-TNFR2 Program to Treat Solid Tumors
Feb 27, 2019
Silverback Therapeutics to Present Data for Lead Therapeutic Candidate SBT6050 at American Association of Cancer Research Annual Conference
Feb 05, 2019
BioInvent CSO to Present F.I.R.S.T.(TM) Discovery Platform at SLAS2019
Feb 04, 2019
Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque's Deep-Primed T Cell Immunotherapies
Jan 03, 2019
AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39
Dec 11, 2018
OncoSec Presents New Data Showing A Single Cycle Of Monotherapy TAVO(TM) Can Generate Productive Immune Responses In Triple Negative Breast Cancers (TNBC)
Nov 19, 2018
Stem Cells Could Prevent Tissue Damage Caused by Radiotherapy
Nov 12, 2018
Torque Presents Preclinical Data for Deep IL-15 Primed T Cells, Deep IL-12 Primed T Cells, and for the Slipstream(TM) Process for Manufacturing These First-in-Class, Multi-Target Cellular Immunotherapies
Nov 08, 2018
Actym Therapeutics Will Present Data at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 06, 2018
Codiak BioSciences Presents First Data on exoSTING - A Novel Engineered Exosome Therapeutic Targeting Checkpoint Refractory Tumors at the Society for Immunotherapy of Cancer's 33rd Annual Meeting